Vanda Pharmaceuticals Inc. · NASDAQ:VNDA
Duncan Charles Cliff received 57,101 Vanda Pharmaceuticals Inc. shares as an award (Form 4)
Traded Apr 22, 2026 · Filed Apr 24, 2026
On Apr 22, 2026, Duncan Charles Cliff (Director) received 57,101 Vanda Pharmaceuticals Inc. shares as an award, leaving 57,101 shares. Filed Apr 24, 2026 (Form 4).
- Awarded
- 57,101 shares
- Holding after
- 57,101 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 22, 2026 | Common Stock | Award | 57,101 | 57,101 | Direct |
Source
Related
- Vanda Pharmaceuticals Inc.
- Duncan Charles Cliff
- Vanda Pharmaceuticals Inc. shareholders
- Form 4 · Duncan Charles Cliff · Jun 8, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 9, 2026
- Schedule 13G · Millennium Management LLC · Aug 19, 2026
- Schedule 13G · AQR Capital Management LLC · Aug 13, 2026
- Form 4 · McGuire Daniel Patrick · Jun 8, 2026
- Form 4 · Chrousos Phaedra · Jun 8, 2026